June 8, 2022
FDA: Class I recall of Philips Respironics V60, V60 Plus Ventilators
Editor's Note
The Food and Drug Administration on June 3 identified the recall by Philips Respironics of all V60 and V60 Plus Ventilators as Class I, the most serious.
The recall was initiated because an internal power fluctuation may cause the ventilator to shut down unintentionally with or without any visible or audible alarms. Such failures may lead to patients being deprived of oxygen for an extended time.
As of April 14, there have been 4 injuries and 1 death reported. Distribution dates were May 1, 2009, to December 22, 2021.
Free Daily News
- Contribute to perioperative education with the 2024 OR Manager Salary/Career Survey
- Supply chain stability improves, but threats remain
- Private equity healthcare ownership draws new scrutiny
- Share your expertise! Topics, speakers sought for 2025 ORBMC
- FDA approves imaging drug for detecting cancer after lumpectomy
- Penn Medicine anesthesia, waste initiatives boost OR sustainability
- Survey assesses continued impact of Change Healthcare cyberattack
- WHO sounds alarm on potential spread of bird flu
- Allison Massari to deliver hopeful, empowering keynote address at OR Manager Conference 2024
- Neurosurgery trial: Early evacuation improves long-term hemorrhage outcomes
© Access Intelligence, LLC. All rights reserved. | Privacy Policy | Diversity, Equity, Inclusion & Belonging